Viviana Guadagnuolo

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations.

Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations.

Journal: Leukemia
Published: March 11, 2021

Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid Leukemia.

Novel and Rare Fusion Transcripts Involving Transcription Factors and Tumor Suppressor Genes in Acute Myeloid Leukemia.

Journal: Cancers
Published: October 16, 2019

Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study.

Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study.

Journal: Bone marrow transplantation
Published: May 08, 2018

Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.

Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.

Journal: Cancer
Published: April 13, 2018

Chromothripsis in acute myeloid leukemia: biological features and impact on survival.

Chromothripsis in acute myeloid leukemia: biological features and impact on survival.

Journal: Leukemia
Published: August 04, 2017

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis.

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis.

Journal: Leukemia
Published: October 06, 2016

Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia.

Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia.

Journal: Oncotarget
Published: February 12, 2016

The human Smoothened inhibitor PF-04449913 induces exit from quiescence and loss of multipotent Drosophila hematopoietic progenitor cells.

The human Smoothened inhibitor PF-04449913 induces exit from quiescence and loss of multipotent Drosophila hematopoietic progenitor cells.

Journal: Oncotarget
Published: December 09, 2015

In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia.

In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia.

Journal: Journal of hematology & oncology
Published: July 09, 2015

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia.

Journal: Journal of translational medicine
Published: May 06, 2015

A case report of acute myeloid leukemia and neurofibromatosis 1.

A case report of acute myeloid leukemia and neurofibromatosis 1.

Journal: Hematology reports
Published: April 02, 2013

IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia.

IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia.

Journal: PloS one
Published: January 15, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026